Clinical Trial Details
| Trial ID: | L3845 |
| Source ID: | NCT03180281 |
| Associated Drug: | Dpp4 |
| Title: | Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell |
| Acronym: | TOND |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: DPP4|DRUG: Insulin|DRUG: SU |
| Outcome Measures: | Primary: Fasting blood glucose,glycosylated hemoglobin(GHbA1c), mmol/L,%, From date of randomization until the date of first documented progression, assessed up to 3 months | Secondary: weight loss, kilograms, From date of randomization until the date of first documented progression, assessed up to 3 months|Lipid changes, mmol/L, From date of randomization until the date of first documented progression, assessed up to 3 months|Incidence of hypoglycemia, times, From date of randomization until the date of first documented progression, assessed up to 3 months |
| Sponsor/Collaborators: | Sponsor: First Affiliated Hospital Xi'an Jiaotong University |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | |
| Enrollment: | 135 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2017-07-01 |
| Completion Date: | 2020-01-01 |
| Results First Posted: | |
| Last Update Posted: | 2017-06-08 |
| Locations: | First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, Shaanxi, 710061, China |
| URL: | https://clinicaltrials.gov/show/NCT03180281 |
